Creso Pharma (ASX: CPH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Creso Pharma Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Creso Pharma (ASX: CPH)
Latest News
Share Gainers
This small-cap ASX biotech's share price is soaring today
Share Gainers
Why Afterpay, Costa, Creso Pharma, & GrainCorp are ending the week with a bang
Share Gainers
Cannabis company Creso Pharma up 36% on takeover approach
Share Gainers
Why this recently-listed ASX cannabis share price soared 25% yesterday
Share Market News
Here's how these ASX cannabis shares have performed in 2019
Share Gainers
The AusCann share price is flying high and up 36% in a month
Share Gainers
Joint agreement: Cannabis contract lifts Creso share price 7%
Share Gainers
Why Ausdrill, Australian Mines, Creso Pharma, and TPG Telecom shares stormed higher today
⏸️ Investing
Can these ASX pot stocks deliver growth in 2019?
Share Market News
ALL ORDINARIES finishes lower Wednesday: 8 shares you missed
Share Gainers
ASX cannabis shares have started the year on a high
Share Gainers
Why AGL Energy, Creso Pharma, RPMGlobal, and Starpharma shares pushed higher today
CPH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Creso Pharma
Creso Pharma Ltd. develops, registers and commercializes pharmaceutical-grade cannabis and hemp-hemp-derived therapeutic, nutraceutical, and lifestyle products with wide patient and consumer reach for human and animal health. It operates through the following segments: Creso Pharma Switzerland GmbH in Switzerland, Kunna S.A.S. located in Colombia, Creso Pharma Limited in Australia and other. The company was founded by Adam Blumenthal, Miri Halperin Wernli and Boaz Wachtel on November 20, 2015 and is headquartered in Nedlends, Australia.
